CRNO B — Cereno Scientific AB Share News
0.000.00%
- SEK1.50bn
- SEK1.60bn
Brief: Cereno Scientific Applies For A Patent
Brief: Cereno Scientific Appoints Daniel Brodén New CFO
Brief: Cereno Scientific Q1 Pre-Tax Loss Widens To SEK 5.3 Mln
Brief: Cereno Scientific Conducts Rights Issue Of About SEK 55.6 Million
Brief: Cereno Scientific Repays Remaining Convertible Loan
Brief: Cereno Scientific Gets Patent Approval In Australia
Brief: Cereno Scientific Repays SEK 2.6 Mln Of Convertible Loan To EHGOSF
Brief: Cereno Scientific Ends Financing Solution With European High Growth Opportunities Securitization Fund
Brief: Cereno Scientific Q4 Pre-tax Loss Widens To SEK 4.01 Mln
Brief: Cereno Scientific Recalls Tranche Of Convertible Bonds And Pauses Financing From EHGOSF
Brief: Cereno Scientific Has Issued The Seventh Tranche
Brief: Cereno Scientific: Patent Grant in US
Brief: Cereno Scientific Receives Patent Approval In US For Use Of Drug Candidate CS1
Brief: Cereno Scientific And OCT Sign Contract For Phase II Study In Patients Undergoing Knee Replacement
Brief: Cereno Scientific Issues 5th Tranche Of Convertible Bonds
Brief: Cereno Scientific Q2 Loss After Financial Widens To SEK 3.1 Mln
Brief: Cereno Scientific Issues The Fourth Tranche Of Convertible Bonds
Brief: Cereno Scientific: Positive Results From Study With CS1
Brief: Cereno Scientific Initiates Collaboration With Cro Partner Oct To Conduct A Phase Ii Study